000			02010 a2200577 4500
005			20250513231136.0
264		0	_c20010405
008			200104s 0 0 eng d
022			_a0027-8874
024	7		_a10.1093/jnci/93.4.284 _2doi
040			_aNLM _beng _cNLM
100	1		_aHarro, C D
245	0	0	_aSafety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. _h[electronic resource]
260			_bJournal of the National Cancer Institute _cFeb 2001
300			_a284-92 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aAlum Compounds _xadministration & dosage
650	0	4	_aAntibodies, Viral _xblood
650	0	4	_aBaculoviridae
650	0	4	_aDouble-Blind Method
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunization Schedule
650	0	4	_aImmunoglobulins _xblood
650	0	4	_aInjections, Intramuscular
650	0	4	_aMale
650	0	4	_aPapillomaviridae _ximmunology
650	0	4	_aPapillomavirus Vaccines
650	0	4	_aPolysorbates _xadministration & dosage
650	0	4	_aRecombinant Proteins
650	0	4	_aReference Values
650	0	4	_aSqualene _xadministration & dosage
650	0	4	_aViral Vaccines _xadministration & dosage
700	1		_aPang, Y Y
700	1		_aRoden, R B
700	1		_aHildesheim, A
700	1		_aWang, Z
700	1		_aReynolds, M J
700	1		_aMast, T C
700	1		_aRobinson, R
700	1		_aMurphy, B R
700	1		_aKarron, R A
700	1		_aDillner, J
700	1		_aSchiller, J T
700	1		_aLowy, D R
773	0		_tJournal of the National Cancer Institute _gvol. 93 _gno. 4 _gp. 284-92
856	4	0	_uhttps://doi.org/10.1093/jnci/93.4.284 _zAvailable from publisher's website
999			_c11120027 _d11120027